Receipt of Novel Hormonal Therapy for Advanced Prostate Cancer Varies With Race

2 years ago 86
THURSDAY, Dec. 28, 2023 (HealthDay News) -- For Medicare beneficiaries with advanced prostate cancer (PCa), receipt of novel hormonal therapy (NHT) agents...
Read Entire Article